By Samuetta Hill Drew Last week’s article reviewed the Johnson & Johnson’s Jassen COVID-19 vaccine cases which prompted the Food and Drug Administration (FDA) and the Centers for Disease Control and Prevention (CDC) to recommend a “pause” until further review. The “pause” was initiated by the CDC and the FDA on April 13 and lifted […]
